As glaucoma specialists, we find ourselves at a crossroads where the science of intervention meets the art of patient counseling. The interventional era has brought us remarkable tools, but it is the surgeon’s psyche, and our approach to patient conversations, that often determines outcomes.
Glaucoma remains a silent adversary. Patients rarely feel its presence until it is too late, and don’t appreciate the irreversibility of glaucoma damage. This asymptomatic nature makes adherence a challenge, and the conversation about it is rarely comfortable. Many patients fear eye surgery more than blindness itself, and the prospect of intervention can seem daunting.
Too often, we fall into the trap of equivalence: “You can choose drops or laser.” Unsurprisingly, most choose drops, perceiving them as the lesser evil. Framing glaucoma as benign, or drops as low risk, does little to motivate meaningful action. Patients look to us not for a menu of options, but for guidance, recommendations, and—sometimes—clear instructions.
Given these challenges, what actually works? I suggest we start by tying the intervention to the patient’s own complaints. If their eyes are dry, if drops run out, if vision fluctuates—these are openings for meaningful dialogue. Reframe glaucoma as a nonbenign disease, and, when appropriate, reframe intervention as the safer path. Make a strong, confident recommendation. Evidence supports us: Laser can be safer than drops, and early intervention may help patients avoid more invasive surgery down the line.
The concept of “pre-suasion” is powerful here. Prep the patient’s mind in advance to find a more receptive ear. Elicit and align with the patient’s identity and values—position the recommendation within what the patient defines as important. Be consistent and spread the conversation out over several visits; early agreement on concepts leads to better follow-through.
We already know how to do this. Consider the Zhongshan Angle Closure Prevention Trial: hundreds of eyes require iridotomy just to prevent a single case of clinically meaningful angle closure. Yet every day doctors have no trouble convincing patients to undergo iridotomy. Why? Because the conversation was clear, the recommendation strong, and the rationale sound.
Don’t go it alone. Enlist your team as drop-free ambassadors. Scribes and technicians often hear about dry eye first, so they can plant the seed for intervention, reinforce your message, and provide a sense of consensus to the patient.
In summary: Listen to your patients’ symptoms. Reframe glaucoma and drops with appropriate high risk. Make a clear recommendation. Our patients want guidance, not equivalence. And enlist your team to reinforce the message. The interventional era is here, but it’s our approach to counseling that will define its success. GP
